Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-17

Clinical Trial Update: Myostatin and Irisin Levels in Predicting the Outcome of Patients With Systemic Inflammation: A Prospective Observational Study

View source ↗

Summary

A completed prospective observational study from Charles University evaluates whether myostatin and irisin levels can predict outcomes in patients with systemic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Systemic Inflammatory Response Syndrome (SIRS) | Status: COMPLETED